U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067307) titled 'Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy' on July 05.
Brief Summary: Melatonin is an attractive candidate with anticancer activities previously reported in various preclinical and clinical studies. Melatonin not only involves regulating biological rhythms and endocrine function but also functions in the occurrence, development, and treatment of cancer. There is a number of possible mechanisms by which melatonin may exert its anticancer effects. These mechanisms may include potent antioxidant, immunomodulating, oncostatic, antiproliferative, and estrogen-modulating properties. Regarding the immune-potent...